BMEA - CIK 0001840439
The table below shows Biomea Fusion, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $9.12M | $14.40M | $16.57M | $22.90M | $25.24M | $27.24M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.65M |
| $4.20M |
| $4.71M |
| $6.82M |
| $4.83M |
| $6.79M |
| Operating income | -$12.77M | -$20.80M | -$21.28M | -$29.71M | -$30.07M | -$34.04M |
| Income tax | - | - | - | - | - | - |
| Net income | -$12.41M | -$16.41M | -$20.74M | -$29.26M | -$29.30M | -$32.79M |
| EPS (diluted) | -$0.17 | -$0.27 | -$0.51 | -$0.80 | -$0.81 | -$0.91 |